These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4927959)

  • 1. [Comparative study of the activity of 6 antileprosy drugs].
    Languillon J
    Med Trop (Mars); 1969; 29(6):694-8. PubMed ID: 4927959
    [No Abstract]   [Full Text] [Related]  

  • 2. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of leprosy.
    Leiker DL
    Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
    Waters MF; Pettit JH
    Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical trial of sulforthomidine ('Fanasil' Roche) in lepromatous leprosy.
    Currie G
    Lepr Rev; 1966 Oct; 37(4):205-8. PubMed ID: 5341699
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of a trial of dapsone vs placebo in lepromatous leprosy.
    Levy L; Murray LP
    Int J Lepr Other Mycobact Dis; 1967; 35(3):393-4. PubMed ID: 4917111
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of leprosy].
    Schirren C; Piening E
    Arch Klin Exp Dermatol; 1970; 237(1):344-6. PubMed ID: 4190468
    [No Abstract]   [Full Text] [Related]  

  • 9. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pilot-trial of treatment of leprosy by pig's thymosin combined with dapsone (author's transl)].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):198-200. PubMed ID: 6459183
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses.
    Opromolla DV
    Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorimetric screening of dapsone in urine for drug trials.
    Balakrishnan S
    Lepr India; 1980 Apr; 52(2):245-8. PubMed ID: 7005540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of leprosy.
    Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial results of prospective controlled treatment trials in leprosy].
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1984; 46(3):207-19. PubMed ID: 6391013
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled trials in the chemotherapy of leprosy.
    Long ER
    Int J Lepr Other Mycobact Dis; 1967; 35(3):388-91. PubMed ID: 4917110
    [No Abstract]   [Full Text] [Related]  

  • 17. Blind trial of weekly doses of sulforthomidine (fanasil (Roche)) and Disulone in lepromatous leprosy. Comparison of results after thirty months of treatment.
    Languillon J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):471-5. PubMed ID: 4948086
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations on the treatment of leprosy with Lederkyn, DDS and new tuberculostatic substances.
    Mohr W
    Int J Lepr Other Mycobact Dis; 1971; 39(2):476-8. PubMed ID: 4948087
    [No Abstract]   [Full Text] [Related]  

  • 19. WHO expert committee on leprosy.
    World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
    Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
    Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.